(2022/01/14)
p. 25914 - 25921
(2021/11/09)p. 212 - 215
(2020/11/26)p. 1514 - 1520
(2020/10/12)(2019/06/27)
(2018/10/11)
p. 1035 - 1040
(2018/09/25)(2018/09/21)
p. 16783 - 16790
(2018/11/23)(2018/09/26)
p. 1355 - 1358
(2018/02/14)(2017/07/06)
p. 843 - 848
(2017/06/13)p. 84 - 89
(2016/04/19)p. 5721 - 5724
(2015/03/30)p. 1888 - 1895
(2013/11/06)p. 1661 - 1667
(2013/05/21)p. 713 - 717
(2012/03/11)(2012/03/27)
p. 10462 - 10469
(2011/10/09)p. 3966 - 3972
(2010/11/18)p. 2094 - 2099
(2010/12/25)p. 3742 - 3752
(2010/04/05)(2009/01/24)
(2008/06/13)
(2010/10/20)
p. 2465 - 2470
(2007/10/03)(2008/06/13)
(2008/06/13)
(2008/06/13)
(2010/02/05)
(2008/06/13)
(2008/06/13)
p. 67 - 83
(2007/10/03)p. 869 - 873
(2007/10/03)p. 6588 - 6597
(2007/10/03)(2008/06/13)
(2008/06/13)
p. 2948 - 2950
(2007/10/03)p. 2135 - 2138
(2007/10/02)p. 611 - 617
(2007/10/02)p. 3183 - 3188
(2007/10/02)p. 1446 - 1454
(2007/10/02)(2008/06/13)
(2008/06/13)
(S)-4,11-diethyl-4-hydroxy-9-methoxy-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
(S)-10-hydroxycamptothecin
propionaldehyde
7-ethyl-10-hydroxy-18,19-dehydrocamptothecin
ethyl 3-((4-methoxy-2-propionylphenyl)amino)-3-oxopropanoate